Six companies and five SPACs entered the public market raising about $2 billion. The week's deals mostly included uplistings, cross-listings, and micro-caps, with biotech Revolution Medicines (RVMD) soaring in the standout IPO of the week. Luxury shoemaker Cole Haan (CLHN) submitted an initial filing this week. The Renaissance Capital IPO Market Index is up 11.2% YTD compared to the S&P's 4.4%, a strong sign for issuance in March.
Revolution Medicines priced at the high end of the upwardly-revised range, raising $238 million at a $1 billion market cap. The Third Rock-backed biotech is developing cancer